Skip to main content
×
Home
    • Aa
    • Aa

Clinical and Economic Impact of Multidrug Resistance in Nosocomial Acinetobacter baumannii Bacteremia

  • Nan-Yao Lee (a1), Hsin-Chun Lee (a1) (a2), Nai-Ying Ko (a3), Chia-Ming Chang (a1), Hsin-I Shih, Chi-Jung Wu (a1) and Wen-Chien Ko (a1) (a2)...
Abstract
Objective.

To investigate the impact of antimicrobial resistance on clinical and economic outcomes among hospitalized patients with multidrug-resistant (MDR) Acinetobacter baumannii bacteremia.

Design.

A retrospective, matched-cohort study.

Setting.

A tertiary care university teaching hospital

Methods.

A matched case-control (1:1) study was conducted to compare the differences in clinical and economic outcomes of patients with MDR A. baumannii bacteremia and patients with non-MDR A. baumannii bacteremia. Case patients were matched to control patients on the basis of sex, age, severity of underlying and acute illness, and length of hospital stay before onset of bacteremia.

Results.

Forty-six (95.8%) of 48 cases with MDR A. baumannii bacteremia were eligible for the study and matched with appropriate controls. The sepsis-related mortality rate was 34.8% among cases and 13.0% among controls, for an attributable mortality rate of 21.8% (adjusted odds ratio, 4.1 [95% confidence interval, 1.1-15.7]; P = .036). After the onset of bacteremia, cases and controls had a significantly different length of hospital stay (54.2 vs 34.1 days; P = .006), hospitalization cost (US$9,349 vs US$4,865; P = .001 ), and antibiotic therapy cost (US$2,257 vs US$1,610; P = .014). Thus, bacteremia due to MDR A. baumannii resulted in 13.4 days of additional hospitalization and US$3,758 of additional costs, compared with bacteremia due to non-MDR A. baumannii.

Conclusions.

Patients with MDR A. baumannii bacteremia had a higher mortality rate and incurred greater medical costs than patients with non-MDR A. baumannii bacteremia.

Copyright
Corresponding author
Department of Internal Medicine, National Cheng Kung University Hospital, No. 138, Sheng Li Road, 704, Tainan, Taiwan (winston@mail.ncku.edu.tw)
References
Hide All
1. JF Acar . Consequences of bacterial resistance to antibiotics in medical practice. Clin Infect Dis 1997;24(suppl 1): S17S18.

2. SD Holmberg , SL Solomon , PA Blake . Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987;9:10651078.

3. C Urban , S Segal-Maurer , JJ Rahal . Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 2003;36:12681274.

5. JM Cisneros , J Rodriguez-Bano . Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002;8:687693.

6. H Seifert , A Strate , G Pulverer . Nosocomial bacteremia due to Acinetobacter baumannii: clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 1995;74:340349.

7. JM Cisneros , MJ Reyes , J Pachon , et al.Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 1996;22:10261032.

8. WR McCabe , GG Jackson . Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962;110:847855.

9. JR Le Gall , S Lemeshow , F Saulnier . A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:29572963.

10. VL Yu , CC Chiou , C Feldman , et al.An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003;37:230237.

11. DL Paterson . The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006;43(suppl 2): S43S48.

12. JS Garner , WR Jarvis , TG Emori , TC Horan , JM Hughes . CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128140.

13. D Pittet , D Tarara , RR Wenzel Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:15981601.

14. JY Fagon , J Chastre , A Novara , P Medioni , C Gibert . Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med 1993;19:137144.

17.National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. Am J Infect Control 1996;24:380388.

18.National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999;27:520532.

20. SE Cosgrove . The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006;42(suppl 2): S82S89.

22. SJ Wilson , CJ Knipe , MJ Zieger , et al.Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital. Am J Infect Control 2004;32:342344.

23. TK Jellison , PS McKinnon , MJ Rybak . Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam. Pharmacotherapy 2001;21:142148.

24. S Blot , K Vandewoude , D De Bacquer , F Colardyn . Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 2002;34:16001606.

25. DP Raymond , SJ Pelletier , TD Crabtree , HL Evans , TL Pruett , RG Sawyer . Impact of antibiotic-resistant gram-negative bacilli infections on outcome in hospitalized patients. Crit Care Med 2003;31:10351041.

26. B Digiovine , C Chenoweth , C Watts , M Higgins . The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999;160:976981.

27. Y Carmeli , N Troillet , AW Karchmer , MH Samore . Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 1999;159:11271132.

28. R Zaragoza , A Artero , JJ Camarena , S Sancho , R Gonzalez , JM Nogueira . The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect 2003;9:412418.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 5 *
Loading metrics...

Abstract views

Total abstract views: 216 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 19th October 2017. This data will be updated every 24 hours.